Rita K. Schmutzler

9.3k total citations · 1 hit paper
65 papers, 2.4k citations indexed

About

Rita K. Schmutzler is a scholar working on Genetics, Molecular Biology and Cancer Research. According to data from OpenAlex, Rita K. Schmutzler has authored 65 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Genetics, 21 papers in Molecular Biology and 16 papers in Cancer Research. Recurrent topics in Rita K. Schmutzler's work include BRCA gene mutations in cancer (31 papers), Cancer Genomics and Diagnostics (12 papers) and Genetic factors in colorectal cancer (10 papers). Rita K. Schmutzler is often cited by papers focused on BRCA gene mutations in cancer (31 papers), Cancer Genomics and Diagnostics (12 papers) and Genetic factors in colorectal cancer (10 papers). Rita K. Schmutzler collaborates with scholars based in Germany, Sweden and United States. Rita K. Schmutzler's co-authors include Judith Balmañà, Niklas Loman, Salomon M. Stemmer, Ayala Hubert, Michael Friedländer, Ronnie Shapira‐Frommer, M. William Audeh, Bella Kaufman, Georgeta Fried and Susan M. Domchek and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Rita K. Schmutzler

58 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation

2014 1.2k citations Rita K. Schmutzler, Judith Balmañà et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rita K. Schmutzler Germany	19	1.4k	1.2k	695	618	506	65	2.4k
Rachel Brough United Kingdom	21	2.1k 1.5×	2.4k 2.0×	480 0.7×	448 0.7×	288 0.6×	39	3.1k
Rebecca Kristeleit United Kingdom	27	1.6k 1.2×	1.4k 1.2×	299 0.4×	400 0.6×	711 1.4×	147	2.9k
Rita K. Schmutzler Germany	22	2.7k 1.9×	2.5k 2.1×	1.3k 1.9×	917 1.5×	488 1.0×	49	4.1k
Carrie A. Adelman United States	17	1.5k 1.0×	1.6k 1.3×	372 0.5×	729 1.2×	124 0.2×	29	3.0k
Monique A. Spillman United States	23	581 0.4×	1.7k 1.5×	735 1.1×	595 1.0×	325 0.6×	52	2.5k
T. Khanh United States	26	991 0.7×	1.6k 1.4×	142 0.2×	473 0.8×	103 0.2×	57	2.5k
Lars Hanker Germany	25	1.0k 0.7×	827 0.7×	185 0.3×	513 0.8×	724 1.4×	100	2.4k
Maaike P.G. Vreeswijk Netherlands	22	518 0.4×	992 0.9×	649 0.9×	363 0.6×	189 0.4×	50	1.7k
Heather Thorne Australia	18	1.1k 0.8×	1.2k 1.0×	568 0.8×	761 1.2×	67 0.1×	40	2.2k
Christopher J. Lafargue United States	16	640 0.5×	947 0.8×	131 0.2×	567 0.9×	141 0.3×	30	1.8k

Countries citing papers authored by Rita K. Schmutzler

Since Specialization

Citations

This map shows the geographic impact of Rita K. Schmutzler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rita K. Schmutzler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rita K. Schmutzler more than expected).

Fields of papers citing papers by Rita K. Schmutzler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rita K. Schmutzler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rita K. Schmutzler. The network helps show where Rita K. Schmutzler may publish in the future.

Co-authorship network of co-authors of Rita K. Schmutzler

This figure shows the co-authorship network connecting the top 25 collaborators of Rita K. Schmutzler. A scholar is included among the top collaborators of Rita K. Schmutzler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rita K. Schmutzler. Rita K. Schmutzler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kautz‐Freimuth, Sibylle, Anke Steckelberg, Frank Vitinius, et al.. (2025). Factors influencing role preferences in decision-making of healthy women with BRCA1/2 pathogenic variants: subanalysis from a randomised controlled decision coaching trial. BMC Cancer. 25(1). 164–164. 1 indexed citations

Jenetzky, Ekkehart, Rüdiger Rupp, Christoph Engel, et al.. (2024). Recommended data elements for health registries: a survey from a German funding initiative. BMC Medical Informatics and Decision Making. 24(1). 136–136.

Hanson, Helen, Laura M. Amendola, Judith Balmañà, et al.. (2023). Management of individuals with germline pathogenic/likely pathogenic variants in CHEK2: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). Genetics in Medicine. 25(10). 100870–100870. 29 indexed citations

Brédart, Anne, Antoine De Pauw, Amélie Anota, et al.. (2022). Genetic clinicians' confidence in BOADICEA comprehensive breast cancer risk estimates and counselees' psychosocial outcomes: A prospective study. Clinical Genetics. 102(1). 30–39. 2 indexed citations

Brédart, Anne, Alejandra Cano, Antoine De Pauw, et al.. (2019). How to facilitate psychosocial adjustment in women tested for hereditary breast or ovarian cancer susceptibility? Insights from network analysis. Psycho-Oncology. 29(3). 550–556. 5 indexed citations

Brédart, Anne, Jean‐Luc Kop, Alejandra Cano, et al.. (2019). Psychosocial problems in women attending French, German and Spanish genetics clinics before and after targeted or multigene testing results: an observational prospective study. BMJ Open. 9(9). e029926–e029926. 9 indexed citations

Weber‐Lassalle, Konstantin, Philipp Harter, Jan Hauke, et al.. (2018). Diagnosis of Li-Fraumeni Syndrome: Differentiating TP53 germline mutations from clonal hematopoiesis. Human Mutation. 39(12). 2040–2046. 17 indexed citations

Ernst, Corinna, Eric Hahnen, Christoph Engel, et al.. (2018). Performance of in silico prediction tools for the classification of rare BRCA1/2 missense variants in clinical diagnostics. BMC Medical Genomics. 11(1). 35–35. 75 indexed citations

Yang, Rongxi, Sarah Schott, Jörg Heil, et al.. (2017). The association between breast cancer and S100P methylation in peripheral blood by multicenter case–control studies. Carcinogenesis. 38(3). 312–320. 39 indexed citations

10.

Hahnen, Eric, Klaus Baumann, André Heimbach, et al.. (2016). Prevalence of somatic mutations in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1 study).. Journal of Clinical Oncology. 34(15_suppl). 5544–5544. 5 indexed citations

11.

Rhiem, Kerstin & Rita K. Schmutzler. (2013). Übersicht - Familiäres Mamma- und Ovarialkarzinom. TumorDiagnostik & Therapie. 34(3). 127–130.

12.

Wang, Furu, Zhibin Hu, Rongxi Yang, et al.. (2010). A variant affecting miRNAs binding in the circadian gene Neuronal PAS domain protein 2 (NPAS2) is not associated with breast cancer risk. Breast Cancer Research and Treatment. 127(3). 769–775. 8 indexed citations

13.

Graeser, Monika, et al.. (2009). Association of hormone receptor status with grading, age of onset, and tumor size in BRCA1-associated breast cancer. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 454(5). 519–524. 5 indexed citations

14.

Schmutzler, Rita K.. (2006). Familial Breast Cancer – What are the Choices, What Are the Questions?. Breast Care. 1(1). 6–7. 1 indexed citations

15.

Hemminki, Kari, Claus R. Bartram, Kerstin Wagner, et al.. (2006). Association of Prolactin and Its Receptor Gene Regions with Familial Breast Cancer. The Journal of Clinical Endocrinology & Metabolism. 91(4). 1513–1519. 47 indexed citations

16.

Bosse, Kristin, Kerstin Rhiem, Barbara Wappenschmidt, et al.. (2006). Screening for ovarian cancer by transvaginal ultrasound and serum CA125 measurement in women with a familial predisposition: A prospective cohort study. Gynecologic Oncology. 103(3). 1077–1082. 41 indexed citations

17.

Frank, Bernd, Kari Hemminki, Justo Lorenzo Bermejo, et al.. (2005). TP53-binding protein variants and breast cancer risk: a case-control study. Breast Cancer Research. 7(4). R502–5. 11 indexed citations

18.

Wirtenberger, Michael, Sandrine Tchatchou, Kari Hemminki, et al.. (2005). Association of genetic variants in the Rho guanine nucleotide exchange factor AKAP13 with familial breast cancer. Carcinogenesis. 27(3). 593–598. 35 indexed citations

19.

Lehrer, Steven, et al.. (1993). An estrogen receptor genetic polymorphism and a history of spontaneous abortion ? Correlation in women with estrogen receptor positive breast cancer but not in women with estrogen receptor negative breast cancer or in women without cancer. Breast Cancer Research and Treatment. 26(2). 175–180. 32 indexed citations

20.

Schmutzler, Rita K. & K. Diedrich. (1990). Basic and clinical aspects of GnRH‐agonists in reproduction. International Journal of Gynecology & Obstetrics. 32(4). 311–324. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact